Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system von Shu, Yamin, Ding, Yiling, Liu, Lulu, Zhang, Qilin

Volltext

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib von Guo, Menglin, Shu, Yamin, Chen, Guosong, Li, Juan, Li, Feie

Volltext

A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data von Zhang, Qilin, Ding, Yiling, Shu, Yamin, Chen, Jing

Volltext

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib von Yin, Yanchao, Shu, Yamin, Zhu, Junru, Li, Feie, Li, Juan

Volltext

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax von Yang, Yang, Shu, Yamin, Chen, Guosong, Yin, Yanchao, Li, Feie, Li, Juan

Volltext

Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China von Zhang, Qilin, Wu, Pan, He, Xucheng, Ding, Yufeng, Shu, Yamin

Volltext

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system von Shu, Yamin, He, Xucheng, Wu, Pan, Liu, Yanxin, Ding, Yufeng, Zhang, Qilin

Volltext

Cost-effectiveness of sintilimab plus chemotherapy versus chemotherapy alone as first-line treatment of locally advanced or metastatic oesophageal squamous cell carcinoma von Liu, Lulu, Wang, Lei, Chen, Li, Ding, Yiling, Zhang, Qilin, Shu, Yamin

Volltext

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax von Yang Yang, Yamin Shu, Guosong Chen, Yanchao Yin, Feie Li, Juan Li

Volltext

Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for EGFR-mutated advanced non-small-cell lung cancer in China von Shu, Yamin, Ding, Yufeng, He, Xucheng, Liu, Yanxin, Wu, Pan, Zhang, Qilin

Volltext

Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System von Shu, Yamin, Ding, Yufeng, Liu, Yanxin, Wu, Pan, He, Xucheng, Zhang, Qilin

Volltext

Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report von Liu, Yanxin, Dong, Changjiang, He, Xucheng, Wu, Pan, Shu, Yamin, Chen, Li

Volltext

Cost-effectiveness of nivolumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma von Shu, Yamin, Tang, Ying, Ding, Yufeng, Zhang, Qilin

Volltext

Cost-effectiveness of nivolumab plus ipilimumab versus chemotherapy as first-line therapy in advanced non-small cell lung cancer von Shu, Yamin, Ding, Yiling, Li, Feie, Zhang, Qilin

Volltext

A real-world pharmacovigilance study of FDA Adverse Event Reporting System von Yang, Yang, Shu, Yamin, Chen, Guosong, Yin, Yanchao, Li, Feie, Li, Juan

Volltext

Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System von Liu, Yanxin, Dong, Changjiang, He, Xucheng, Shu, Yamin, Wu, Pan, Zou, Jian

Volltext

Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide von Zhang, Yu, Zhou, Tao, Luo, Li, Cui, Zheng, Wang, Na, Shu, Yamin, Wang, Kai-Ping

Volltext

Chinese angelica polysaccharide derivative for SPECT (Single Photon Emission Computed Tomography) imaging and synthesis method therefor von LUO LI, SONG ZHIZHEN, WANG KAIPING, ZHANG YU, WANG NA, SHU YAMIN, ZHOU TAO

Volltext bestellen

Integration of Pd nanoparticles with engineered pore walls in MOFs for enhanced catalysis von Li, Luyan, Li, Zhixin, Yang, Weijie, Huang, Yamin, Huang, Gang, Guan, Qiaoqiao, Dong, Yemin, Lu, Junling, Yu, Shu-Hong, Jiang, Hai-Long

Volltext

SUMOylation of Warts kinase promotes neural stem cell reactivation von Gao, Yang, Tan, Ye Sing, Lin, Jiaen, Chew, Liang Yuh, Aung, Htet Yamin, Palliyana, Brinda, Gujar, Mahekta R., Lin, Kun-Yang, Kondo, Shu, Wang, Hongyan

Volltext